Literature DB >> 16424212

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Christopher C Kemball1, Eun D Han Lee, Eva Szomolanyi-Tsuda, Thomas C Pearson, Christian P Larsen, Aron E Lukacher.   

Abstract

The requirement for costimulation in antiviral CD8+ T cell responses has been actively investigated for acutely resolved viral infections, but it is less defined for CD8+ T cell responses to persistent virus infection. Using mouse polyoma virus (PyV) as a model of low-level persistent virus infection, we asked whether blockade of the CD40 ligand (CD40L) and CD28 costimulatory pathways impacts the magnitude and function of the PyV-specific CD8+ T response, as well as the humoral response and viral control during acute and persistent phases of infection. Costimulation blockade or gene knockout of either CD28 or CD40L substantially dampened the magnitude of the acute CD8+ T cell response; simultaneous CD28 and CD40L blockade severely depressed the acute T cell response, altered the cell surface phenotype of PyV-specific CD8+ T cells, decreased PyV VP1-specific serum IgG titers, and resulted in an increase in viral DNA levels in multiple organs. CD28 and CD40L costimulation blockade during acute infection also diminished the memory PyV-specific CD8+ T cell response and serum IgG titer, but control of viral persistence varied between mouse strains and among organs. Interestingly, we found that CD28 and CD40L costimulation is dispensable for generating and/or maintaining PyV-specific CD8+ T cells during persistent infection; however, blockade of CD27 and CD28 costimulation in persistently infected mice caused a reduction in PyV-specific CD8+ T cells. Taken together, these data indicate that CD8+ T cells primed within the distinct microenvironments of acute vs persistent virus infection differ in their costimulation requirements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424212     DOI: 10.4049/jimmunol.176.3.1814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.

Authors:  Shinichiro Fuse; Joshua J Obar; Sarah Bellfy; Erica K Leung; Weijun Zhang; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  A critical precursor frequency of donor-reactive CD4+ T cell help is required for CD8+ T cell-mediated CD28/CD154-independent rejection.

Authors:  Mandy L Ford; Maylene E Wagener; Samantha S Hanna; Thomas C Pearson; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

3.  Protection against polyoma virus-induced tumors is perforin-independent.

Authors:  Anthony M Byers; Annette Hadley; Aron E Lukacher
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

Review 4.  Opposing positive and negative regulation of T cell activity during viral persistence.

Authors:  Laura M Fahey; David G Brooks
Journal:  Curr Opin Immunol       Date:  2010-04-08       Impact factor: 7.486

5.  MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.

Authors:  Amelia R Hofstetter; Mandy L Ford; Lucy C Sullivan; Jarad J Wilson; Annette Hadley; Andrew G Brooks; Aron E Lukacher
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

6.  Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.

Authors:  Alyson I Swimm; William Bornmann; Mengxi Jiang; Michael J Imperiale; Aron E Lukacher; Daniel Kalman
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

Review 7.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells.

Authors:  Sixun Yang; Jeffrey Schlom
Journal:  Cancer Immunol Immunother       Date:  2008-08-09       Impact factor: 6.968

Review 9.  The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses.

Authors:  Alison Crawford; E John Wherry
Journal:  Curr Opin Immunol       Date:  2009-03-04       Impact factor: 7.486

10.  Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Authors:  Christopher C Kemball; Eva Szomolanyi-Tsuda; Aron E Lukacher
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.